Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 21 Jul 2026 How Scientists Can Revive Global Health Drug Development Think Global Health
Scientific articles 19 Aug 2026 A serological method’s ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data The Journal of Infectious Diseases
Press releases 13 Feb 2025 DNDi announces organizational strategy update and strengthened executive team
Press releases 10 Feb 2025 The African Union Commission Strengthens Collaboration with the Drugs for Neglected Diseases initiative
Press releases 4 Feb 2025 Hyundai Bio (HDB) and DNDi sign MOU for joint development of Xafty-based dengue treatment
Press releases 30 Jan 2025 DNDi welcomes GHIT support for new collaboration with Eisai for dengue and Zika virus disease
Press releases 30 Jan 2025 IRD, DNDi and Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
